Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors. [Phase 2]
Phase 2 multicenter prospective study assessing arterial infusion chemotherapy and embolization combined with dual immune checkpoint inhibit…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer [NA]
This clinical trial update notes that a study combining stereotactic body radiation with tumor treating fields is currently recruiting for l…
-
CLINICAL_TRIALS other · 2026-01-12Clinical Trial Update: Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer [NA]
Clinical trial status update indicating a study evaluating chemotherapy with or without IMD10 (focused ultrasound) for border-line resectabl…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating the combination of Niraparib and Dostarlimab (TSR-042) in BRCA-mutated unresectable or metastatic cancers including…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
LOTUS-CC is an observational study at the University of Rochester aimed at uncovering subtypes of cancer cachexia in patients with advanced …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation [Phase 1]
This clinical trial entry reports a Phase I study of IX001 TCR-T Injection for advanced pancreatic cancer with KRAS G12V mutation; recruitme…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer
This document outlines a clinical trial aimed at developing a predictive model to assess the efficacy of chemoprevention when combined with …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial [Phase 2]
Phase 2 clinical trial update for pancreatic cancer investigating adaptive neoadjuvant chemotherapy. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: High Dose Omeprazole in Patients With Pancreatic Cancer [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating high-dose omeprazole in patients with exocrine pancreatic cancer; the study is currently in the recru…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for the PLATINUM study evaluating second-line platinum-based chemotherapy for metastatic BRCA1/2- or PALB2-associated …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer [Phase 2]
Phase 2 randomized trial evaluating all-trans retinoic acid (ATRA) in a novel drug combination for pancreatic cancer; the trial is currently…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery [Phase 1]
A Phase 1 study evaluating personalized tumor vaccines in combination with a PD-L1 blocker for resectable pancreatic cancer; the trial is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
This document provides an update on the Phase 2 SMMART-ACT precision medicine trial. It targets patients with advanced breast, ovarian, panc…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer [EARLY_Phase 1]
Early-phase feasibility trial comparing oral ketamine to placebo for anxiety in patients with pancreatic cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
This clinical trial update notes that the study examining WATD and cancer-related fatigue in patients undergoing anti-cancer treatment is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" [NA]
MD Anderson Cancer Center is conducting a clinical trial to evaluate the association between health care provider–assessed ECOG performance …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
A real-world study in China is recruiting to evaluate irinotecan hydrochloride liposome injection II for pancreatic cancer.
-
CLINICAL_TRIALS other · 2026-01-06Clinical Trial Update: Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)
This update notes a continued access program for Tumor Treating Fields in combination with gemcitabine and nab-paclitaxel for adults with lo…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer [Phase 2]
This is a Phase 2 exploratory platform study on precision therapy for advanced pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
This clinical trial update describes the CCANED-CIPHER study, an ongoing investigation using AI-based transcriptomic profiling of platelets …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating a triple regimen of QL1706, lenvatinib, and the AG regimen (nab-paclitaxel plus gemcitabine) as first-li…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating HRS-4642 with gemcitabine, nab-paclitaxel, and adebrelimab for neoadjuvant and adjuvant pancreatic cancer is curren…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Target-specific immunoPET Imaging of Digestive System Carcinoma [NA]
A recruiting clinical trial evaluating a target-specific immunoPET imaging agent for digestive system carcinomas across multiple digestive c…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer [Phase 2]
Completed Phase 2 trial comparing SLOG regimen to modified FOLFIRINOX as first-line therapy for locally advanced unresectable or metastatic …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer [Phase 2, Phase 3]
This clinical trial update describes a Phase II/III study evaluating the efficacy and safety of Surufatinib in combination with Camrelizumab…